TITLE

Factors Predictive of Response to Cyclosporin Treatment for Severe, Steroid-Resistant Ulcerative Colitis

AUTHOR(S)
Rowe, F. Anderson; Walker, John H.; Karp, Loren C.; Vasiliauskas, Eric A.; Plevy, Scott E.; Targan, Stephan R.
PUB. DATE
August 2000
SOURCE
American Journal of Gastroenterology;Aug2000, Vol. 95 Issue 8, p2000
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: Cyclosporin-A (CSA) has been demonstrated to be effective for treatment of severe, steroid-resistant ulcerative colitis (UC). Use of CSA has been limited, however, because of low 1-yr response rates and the potential for complications. The aim of this study is to define clinical and laboratory factors predictive of response in severe, steroid-resistant UC. METHODS: A retrospective review of 36 cases of severe, steroid-resistant UC treated with CSA was performed. Intravenous (i.v.) CSA was administered at an initial dose of 2.5 mg/kg, and oral (p.o.) CSA was given as twice the i.v. dose. Clinical response was recorded and logistic regression analysis was performed on clinical and laboratory factors for prediction of response to CSA. RESULTS: Of 36 patients, 25 responded to i.v. CSA and were switched to p.o. CSA. Of the 25, 13 required colectomy by 9 months. The other 12 patients had a sustained response to CSA and avoided colectomy at 9 months. Overall, 24 of 36 patients treated with CSA required colectomy by 9 months. A high percentage of band neutrophils (bands) on admission was found to be a significant predictor of response to CSA. CONCLUSIONS: Bands on admission are predictive of response to CSA and ultimately, the requirement for surgery in steroid-resistant UC.
ACCESSION #
17651579

 

Related Articles

  • Cyclosporine and inflammatory bowel disease: buying time. Meijssen, M. A. C. // Mediators of Inflammation;Jun98, Vol. 7 Issue 3, p145 

    CYCLOSPORINE is an effective drug in acute exacerbations of corticosteroid resistant ulcerative colitis, but its efficacy to maintain disease remission is not clear. Cyclosporine may not be as effective in Crohn's disease. However, being a rapidly acting immunosuppressant, cyclosporine may be a...

  • MY THOUGHTS ON USING CYCLOSPORINE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE. Korelitz, Burton I. // American Journal of Gastroenterology;Dec1995, Vol. 90 Issue 12, p2085 

    Deals with the use of cyclosporine in the treatment of inflammatory bowel disease (IBD). Rationale in using cyclosporine in IBD and Crohn's disease; Overview of studies on the use cyclosporine in the treatment of IBD and Crohn's disease; Cases of using cyclosporin in patients with pneumonia;...

  • Cyclosporin for Steroid-Refractory Ulcerative Colitis. Actis, Giovanni C. // American Journal of Gastroenterology;Mar2000, Vol. 95 Issue 3, p830 

    Provides information on a study that described the use of cyclosporin for severe steroid-refractory ulcerative colitis. Results of the study.

  • Azathioprine Is Useful in Maintaining Long-Term Remission Induced by Intravenous Cyclosporine in Steroid-Refractory Severe Ulcerative Colitis. Fernández-Bañares, F.; Bertrán, X.; Esteve-Comas, M.; Cabré, E.; Menacho, M.; Humbert, P.; Planas, R.; Gassull, M. A. // American Journal of Gastroenterology;Dec1996, Vol. 91 Issue 12, p2498 

    Background/Aim: Therapeutic regimens with intravenous (i.v.) cyclosporine followed by oral cyclosporine maintenance therapy reduce the need for immediate surgery in steroid-refractory severe ulcerative colitis, but the short-term colectomy rate is still as high as 70%. We report our experience...

  • LONG TERM FOLLOW UP OF UC PATIENTS TREATED WITH CYCLOSPORWI--7 YEAR EXPERIENCE. Campbell, S.; Jewell, D. P. // Gut;Apr2004 Supplement 3, Vol. 53, pA1 

    Cyclosporin (CyA) Rx has emerged as an important agent for rescue Rx in acute severe ulcerative colitis. High 1 year relapse rates advocate a limited role of this treatment in light of CyAs s/e profile. Some advocate CyA only as a stopgap to surgical Rx. There are few data available on longer...

  • A 6-Thioguanine Nucleotide Threshold Level of 400 pmol/8 × 108 Erythrocytes Predicts Azathioprine Refractoriness in Patients With Inflammatory Bowel Disease and Normal TPMT Activity. Roblin, Xavier; Biroulet, Laurent P.; Phelip, Jean M.; Nancey, Stéphane; Flourie, Bernard // American Journal of Gastroenterology;Dec2008, Vol. 103 Issue 12, p3115 

    BACKGROUND AND AIMS: A therapeutic level of 6-thioguanine nucleotides (6-TGN) has been reported in inflammatory bowel disease (IBD) patients under azathioprine (AZA). We investigated the threshold value of 6-TGN that may be predictive of AZA refractoriness and its impact on safety...

  • Subretinal fibrosis and uveitis syndrome associated with ulcerative colitis. Fuentes-Páez, Graciana; Martínez-Osorio, Hernán; Herreras, José M.; Calonge, Margarita // International Journal of Colorectal Disease;Mar2007, Vol. 22 Issue 3, p333 

    We report a case of subretinal fibrosis and panuveitis syndrome as an extraintestinal manifestation of ulcerative colitis. We present an interventional case report of a 40-year-old female patient with inactive ulcerative colitis referred to our center for refractory uveitis in her right eye. She...

  • Comparative tolerability of treatments for inflammatory bowel disease. Stein, R.B.; Hanauer, S.B. // Drug Safety;Nov2000, Vol. 23 Issue 5, p429 

    Despite limited understanding of therapeutic aetiopathogenesis of ulcerative colitis and Crohn's disease, there is a strong evidence base for the efficacy of pharmacological and biological therapies. It is equally important to recognise toxicity of the medical armamentarium for inflammatory...

  • Cyclosporine Enemas for Treatment-Resistant, Mildly to Moderately Active, Left-Sided Ulcerative Colitis. Sandborn, William j.; Tremaine, William J.; Schroeder, Kenneth W.; Steiner, Betty L.; Batts, Kenneth P.; Lawson, George M. // American Journal of Gastroenterology;May1993, Vol. 88 Issue 5, p640 

    Ten patients with treatment-resistant left-sided ulcerative colitis were treated in an open protocol with 350 mg cyclosporine enemas nightly for 4 wk. A 12-point clinical disease activity index (DAI) score was calculated at baseline and after 4 wk. Whole blood and colonic tissue cyclosporine...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics